EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated serum mtDNA in COVID-19 patients is linked to SARS-CoV-2 envelope protein targeting mitochondrial VDAC1, inducing apoptosis and mtDNA release

Anna Shteinfer-Kuzmine, Ankit Verma, Rut Bornshten, Eli Ben Chetrit, Ami Ben-Ya'acov, Hadas Pahima, Ethan Rubin, Yosef Mograbi, Eyal Shteyer, Varda Shoshan-Barmatz iD

Apoptosis · 2024-12 · 29 (11-12) · 2025-2046

DOI: 10.1007/s10495-024-02025-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Apoptosis, online erschienen am 07.10.2024. Verfasst von Anna Shteinfer-Kuzmine und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Biotechnology in the Negev, Beer-Sheva, Israel. Hauptthemen laut MEDLINE: Voltage-Dependent Anion Channel 1, COVID-19, Apoptosis, SARS-CoV-2. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ben-Gurion University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria dysfunction is implicated in cell death, inflammation, and autoimmunity. During viral infections, some viruses employ different strategies to disrupt mitochondria-dependent apoptosis, while others, including SARS-CoV-2, induce host cell apoptosis to facilitate replication and immune system modulation. Given mitochondrial DNAs (mtDNA) role as a pro-inflammatory damage-associated molecular pattern in inflammatory diseases, we examined its levels in the serum of COVID-19 patients and found it to be high relative to levels in healthy donors. Furthermore, comparison of serum protein profiles between healthy individuals and SARS-CoV-2-infected patients revealed unique bands in the COVID-19 patients. Using mass spectroscopy, we identified over 15 proteins, whose levels in the serum of COVID-19 patients were 4- to 780-fold higher. As mtDNA release from the mitochondria is mediated by the oligomeric form of the mitochondrial-gatekeeper—the voltage-dependent anion-selective channel 1 (VDAC1)—we investigated whether SARS-CoV-2 protein alters VDAC1 expression. Among the three selected SARS-CoV-2 proteins, small envelope (E), nucleocapsid (N), and accessory 3b proteins, the E-protein induced VDAC1 overexpression, VDAC1 oligomerization, cell death, and mtDNA release. Additionally, this protein led to mitochondrial dysfunction, as evidenced by increased mitochondrial ROS production and cytosolic Ca 2+ levels. These findings suggest that SARS-CoV-2 E-protein induces mitochondrial dysfunction, apoptosis, and mtDNA release via VDAC1 modulation. mtDNA that accumulates in the blood activates the cGAS-STING pathway, triggering inflammatory cytokine and chemokine expression that contribute to the cytokine storm and tissue damage seen in cases of severe COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Voltage-Dependent Anion Channel 1COVID-19ApoptosisSARS-CoV-2MitochondriaDNA, MitochondrialHumansMiddle AgedMaleFemaleAdult

Stichwörter der Autor:innen

ApoptosisCOVID-19MitochondriaVDAC1mtDNA

Substanzen

Voltage-Dependent Anion Channel 1VDAC1 protein, humanDNA, Mitochondrial

Autor:innen und Institutionen

  • National Institute for Biotechnology in the Negev, Beer-Sheva, Israel.
  • Department of Life Sciences, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.
  • The Shraga Segal Dept. of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, 84105, Beer-Sheva, Israel.
  • Infectious Diseases Unit, Shaare Zedek Medical Center, Hebrew University School of Medicine, Jerusalem, Israel.
  • Shaare Zedek Medical Center, The Juliet Keidan Institute of Paediatric Gastroenterology, Jerusalem, Israel.
  • , Tel Aviv-Yafo, Israel.

ORCID-Profile: Varda Shoshan-Barmatz

Förderung

  • Ben-Gurion University

Zitieren

APA

Shteinfer-Kuzmine, A., Verma, A., Bornshten, R., Ben Chetrit, E., Ben-Ya'acov, A., Pahima, H., Rubin, E., Mograbi, Y., Shteyer, E., & Shoshan-Barmatz, V. (2024). Elevated serum mtDNA in COVID-19 patients is linked to SARS-CoV-2 envelope protein targeting mitochondrial VDAC1, inducing apoptosis and mtDNA release. Apoptosis, 29(11-12), 2025-2046. https://doi.org/10.1007/s10495-024-02025-5

Vancouver

Shteinfer-Kuzmine A, Verma A, Bornshten R, Ben Chetrit E, Ben-Ya'acov A, Pahima H, et al. Elevated serum mtDNA in COVID-19 patients is linked to SARS-CoV-2 envelope protein targeting mitochondrial VDAC1, inducing apoptosis and mtDNA release. Apoptosis. 2024;29(11-12):2025-2046. doi:10.1007/s10495-024-02025-5

BibTeX
@article{ShteinferKuzmine2024,
  author = {Shteinfer-Kuzmine, Anna and Verma, Ankit and Bornshten, Rut and Ben Chetrit, Eli and Ben-Ya'acov, Ami and Pahima, Hadas and Rubin, Ethan and Mograbi, Yosef and Shteyer, Eyal and Shoshan-Barmatz, Varda},
  title = {Elevated serum mtDNA in COVID-19 patients is linked to SARS-CoV-2 envelope protein targeting mitochondrial VDAC1, inducing apoptosis and mtDNA release},
  journal = {Apoptosis},
  year = {2024},
  volume = {29},
  number = {11-12},
  pages = {2025--2046},
  doi = {10.1007/s10495-024-02025-5}
}
Kostenlos starten →